Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica

Summary

The objective of this trial is to assess the clinical efficacy of the modified extract (depigmented and polymerized with glutaraldehyde) of the subcutaneous injection of Parietaria Judaica pollen in the treatment of patients affected by allergic rhinitis/rhinoconjunctivitis ( with or without episodic asthma) induced by hypersensitivity to grass pollen, evaluating the score regarding symptoms and consumption of the medication.

Timeline

Start

2008-02

Primary completion

2013-02

Completion

2013-02

Drugs

Indications